ATP Competitive Inhibitor BMS-794833 Cas 1174046-72-0
ATP Competitive Inhibitor BMS-794833 Cas 1174046-72-0
+ AII PRODUCTS
- Prostaglandins - Custom Synthesis - PARP Inhibitors - PI3K Inhibitors - FAK Inhibitors - AKT Inhibitors - C-Kit Inhibitors - VEGFR Inhibitors - c-Met Inhibitors - CDK Inhibitors - CYP17 Inhibitors - DNA/RNA Inhibitors - mTOR Inhibitors - SRC Inhibitors - Others
Product
|
Size |
Price |
Stock |
Quantity |
|---|---|---|---|
|
Get Quotation Now Add to Cart Bulk Inquiry |
|||
AddThis Sharing Buttons
Share to FacebookFacebookShare to TwitterTwitterShare to PrintPrintShare to EmailEmailShare to PinterestPinterestShare to GmailGmailShare to LinkedInLinkedInShare to Email AppEmail AppShare to TumblrTumblrShare to MoreAddThis
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
|
Product name:BMS-794833 |
Purity:98% min |
|
CAS NO:1174046-72-0 |
Solubility:DMSO100 mg/mL (213.29 mM) |
|
Molecular Formula:C23H15ClF2N4O3 |
Package:Package according to customer requirements |
|
Molecular Weight:468.840 |
Storage:Store at -20℃ |
Quality control
Remarks
BMS-794833 is a potent ATP competitive inhibitor of Met/VEGFR2 with IC50 of 1.7 nM/15 nM. BMS-794833 also inhibits Ron (Met family), Axl (phylogenetically related Axl/Tyro3/Mer subfamily) and Flt-3 with IC50 values less than 3 nM. The compound was selective versus a panel of greater than 200 additional receptor tyrosine kinase (RTKs), non-RTKs and serine/threonine kinases based on biochemical or Ambit binding assays. Moreover, it inhibited the cell growth in GTL-16 gastric carcinomas with an IC50 of 39 nM . In vivo, BMS-794833 exhibited dose-dependent anti-tumor activity against multiple tumor types without overt toxicities at efficacious dose levels.
Related Products
MGCD-265 analog; BMS777607; JNJ-38877605; Tivantinib; AMG-208; AMG-458; NVP-BVU972; Golvatinib; SU11274; PF-04217903; Crizotinib
References
[1] WO2009094417A1
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.